Intelligence Platform

Patents

Browse 56 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12357705

Negatively charged peg-lipid conjugates

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12350383

Cationic lipids containing silicon

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12251470

Lipid nanoparticle formulations

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12129467

Non-liposomal systems for nucleic acid delivery

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12083118

Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12042541

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12043833

Targeted compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12023383

Lipid compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12016929

Lipid formulations for delivery of therapeutic agents

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11904052

Methods for ameliorating infusion reactions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11896672

Targeted nucleic acid conjugate compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11786598

Lipid formulations for delivery of therapeutic agents

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11718852

Non-liposomal systems for nucleic acid delivery

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11712476

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702427

Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11566002

Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues th

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11505551

Methods for preparing substituted pyridinone-containing tricyclic compounds

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11446383

Lipid formulations for delivery of therapeutic agents

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11427823

Targeted compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11420931

Lipid containing formulations

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11395854

Trialkyl cationic lipids and methods of use thereof

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11351118

Methods for ameliorating infusion reactions

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11318098

Liposomal apparatus and manufacturing methods

ARBUTUS BIOPHARMA CORPORATION · Granted Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11298320

Liposomal apparatus and manufacturing methods

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted